skip to primary navigationskip to content

GeneAdviser partners with Birmingham Women’s Hospital to make personalised medicine more accessible

last modified Sep 29, 2016 10:46 AM
The largest genetics laboratory in the NHS brings to the platform their solid tumour sequencing, enabling clinicians to give an individual approach to their patients, tailored to their tumour’s genetic makeup.
GeneAdviser partners with Birmingham Women’s Hospital to make personalised medicine more accessible

 GeneAdvisor's CEO Jelena Aleksic (left) and CTO Robert Stojnic (right)

GeneAdviser is bringing the expertise of Birmingham Women’s Hospital to their ordering platform, where healthcare professionals can now order tests for genetic sequencing of tumour samples, screening for those changes in the tumour that may require clinical action.

Each tumour has a different genetic makeup, which makes it react to therapies very differently. By analysing and monitoring the presence of genetic sequences in a tumour, patients can be prescribed more targeted treatment and screening.

Dr Jelena Aleksic, GeneAdviser’s CEO, commented: “Birmingham Women’s Hospital combines outstanding and comprehensive genetics research and clinical expertise, making it an internationally renowned clinical laboratory. We are delighted to make their excellent genetic testing more accessible to doctors worldwide, helping them provide better care for their patients.”

Professor Michael Griffiths, the Birmingham Women’s Hospital Genetics Laboratory Director, added: "We are excited to join forces with GeneAdviser to facilitate worldwide access to our genetic test portfolio.  As the largest NHS genetics laboratory we already work closely with clinicians across the UK and internationally, and GeneAdviser will allow them to easily order the genetic  tests they need for their patients, whilst streamlining administrative processes for our staff."

Their partnership also expands beyond solid tumour sequencing, bringing forward a selection of high quality genetic tests in oncology and other medical specialties. Other tests from Birmingham Women’s Hospital include their Lucina NIPT (non invasive prenatal testing), a highly accurate genetic prenatal testing that screens for trisomies such as Down syndrome using a single maternal blood sample.

RSS Feed Latest news

First IPO for FreeAgent Central

Nov 22, 2016

Cloud-based accounting software provider, FreeAgent Central have started trading as a public company on the London Stock Exchange's Alternative Investment Market (AIM)

Spectral Edge showcase their Eyeteq and Nighteq technology at the OTTtv World Summit

Nov 17, 2016

ideaSpace West members, Spectral Edge, have been receiving a lot of media attention recently after showcasing their image processing technology at the OTTtv World Summit on the 8th to 10th November, 2016 in London.

Blackboard Announces Acquisition of U.K. Based Fronteer

Oct 26, 2016

Blackboard Inc., a leading education technology company for teaching, learning and student engagement, today announced the acquisition of U.K. based Fronteer, including its flagship Ally product. Ally is designed to help institutions and instructors make course content more accessible for learners.

View all news